SEARCH

SEARCH BY CITATION

References

  • 1
    Hashinski V, Norris JW. The deteriorating stroke. In: MeyerJS, LechnerH, ReivichM, OttEO, AranibarA, eds. Proceedings of the 10th International Salzburg Conference, 1980.
  • 2
    Jones HR, Millikan CH. Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke 1976; 7: 6471.
  • 3
    Jones HR, Millikan CH. Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke 1980; 11: 1737.
  • 4
    Britton M, Rödén Å. Progression of stroke after arrival at hospital. Stroke 1985; 16: 62932.
  • 5
    Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990; 40: 186569.
  • 6
    Carter AB. Anticoagulant treatment in progressing stroke. BMJ 1961:7073.
  • 7
    Baker RN, Browaard JA, Fang HC et al. Anticoagulant therapy in cerebral infarction. Report on a co-operative study. Neurology 1962; 12: 82835.
  • 8
    Fisher CM. The use of anticoagulants in cerebral thrombosis. Neurology 1958; 8: 31131.
  • 9
    Haley EC Jr, Kassell NF, Torner JC. Failure of heparin to prevent progression in progressing ischemic infarction. Stroke 1988; 19: 1014.
  • 10
    Duke RJ, Bloch RF, Turpie AG, Trebilcock R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomised controlled trial. Ann Intern Med 1986; 105: 82528.
  • 11
    Asplund K. Deterioration of acute stroke. In: Del ZoppoGJ, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. Berlin: Springer Verlag, 1994; 11928.
  • 12
    Gautier JC. Stroke in progression. Stroke 1985; 16: 72933.
  • 13
    Asplund K. Any progress on progressing stroke? Cerebrovasc Dis 1992; 2: 3179.
  • 14
    Irino T, Watanabe M, Nishide M, Gotoh M, Tsuchiya T. Angiographical analysis of acute cerebral infarction followed by ‘Cascade’-like deterioration of minor neurological deficit. What is progressing stroke? Stroke 1983; 14: 36368.
  • 15
    Feuerstein G. Eicosanoids in deteriorating stroke. Ann NY Acad Sci 1989: 559; 31322.
  • 16
    Jorgensen L, Torvik A. Ischemic cerebrovascular disease in an autopsy series: Part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci 1969; 9: 285320.
  • 17
    Antiplatelet Trialists’ collaboration. Collaborative overview of randomised trials of antiplatelet therapy – I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81106.
  • 18
    Lewis HD Jr, Davis JW, Archibald DG et al. Protective effect of aspirin against myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396403.
  • 19
    ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 34960.
  • 20
    Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971; 231: 2357.
  • 21
    Hirsh J. Progress review: The relationship between dose of aspirin, side-effects and antithrombotic effectiveness. Stroke 1985; 16: 14.
  • 22
    Rödén-Jüllig Å, Britton M, Gustafsson C, Fugl-Meyer A. Validation of four scales for the acute stage of stroke. J Intern Med 1994; 236: 12536.
  • 23
    Mahony FD, Barhtel DW. Functional evaluation: the Barthel Index. MD State Med J 1965; 14: 6163.
  • 24
    Wayne W. Daniel in Biostatistics: A Foundation for Analysis in the Health Sciences, 6th edn. New York: John Wiley & Sons, 1995.
  • 25
    Douglas C. Montgomery. Design and analysis of experiments, 3rd edn. New York: John Wiley & Sons, 1991.
  • 26
    The SAS system 6.12 for Windows. Cary, NC, USA: SAS Institute Inc.
  • 27
    International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349: 156981.
  • 28
    CAST Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 16419.
  • 29
    Chen ZM, Sandercock P, Pan HC et al. Indication for early aspirin use in acute ischemic strike. Randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAS and IST collaborative group. Stroke 2000; 31: 12409.
  • 30
    Bamford J, Sandercock P, Dennis M, Burn H, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 15216.